shipment_ID,catalog_ID,Formula,stereochemistry,sample_MW,purity,PO,Salt_Name,Salt_ratio,MW_salt,volume(uL),concentration(mM),plate_ID,well,SMILES,Name
ERI-UCB-a0b0dbcb-8,Z4655756144,C20H19N3O3,Achiral,349.383,100,200415-FTE / COVID-19,,,0,40,20,1181202-Y4-23,05_A,COC=1C=CC=CC1NC2CN(C2)C(=O)C3=CC(=O)NC=4C=CC=CC34,"4-{3-[(2-methoxyphenyl)amino]azetidine-1-carbonyl}-1,2-dihydroquinolin-2-one"
PET-UNK-e44ffd04-1,Z1079665436,C14H11ClN4O,Achiral,286.716,100,200415-FTE / COVID-19,,,0,40,20,1181202-Y4-23,05_B,ClC=1C=CC=C(CC(=O)NC2=NN=C3C=CC=CN23)C1,"2-(3-chlorophenyl)-N-{[1,2,4]triazolo[4,3-a]pyridin-3-yl}acetamide"
EDJ-MED-c8e7a002-16,Z4661830692,C14H11ClN4O,Achiral,286.716,97.48,200415-FTE / COVID-19,,,0,40,20,1181202-Y4-23,05_C,ClC=1C=CC=C(CC(=O)NC2=NNC=3C=CN=CC23)C1,"2-(3-chlorophenyl)-N-{1H-pyrazolo[4,3-c]pyridin-3-yl}acetamide"
EDJ-MED-c8e7a002-1,Z4661830652,C16H13ClN2O3,Achiral,316.739,100,200415-FTE / COVID-19,,,0,40,20,1181202-Y4-23,05_D,COC=1C=CC=2C(NC(=O)CC=3C=CC=C(Cl)C3)=NOC2C1,"2-(3-chlorophenyl)-N-(6-methoxy-1,2-benzoxazol-3-yl)acetamide"
MAT-POS-199e2e7c-1,Z4661830651,C16H15ClN2O,Achiral,286.756,95.77,200415-FTE / COVID-19,,,0,40,20,1181202-Y4-23,05_E,ClC=1C=CC=C(CC(=O)NC=2C=NC=C3CCCC32)C1,"2-(3-chlorophenyl)-N-{5H,6H,7H-cyclopenta[c]pyridin-4-yl}acetamide"
EDJ-MED-c8e7a002-12,Z1079623926,C15H12ClN3O,Achiral,285.728,100,200415-FTE / COVID-19,,,0,40,20,1181202-Y4-23,05_F,ClC=1C=CC=C(CC(=O)NC=2C=CC=C3C=NNC23)C1,2-(3-chlorophenyl)-N-(1H-indazol-7-yl)acetamide
ERI-UCB-a0b0dbcb-6,Z4655756143,C21H20N2O4,Racemic or presumed racemic or meso,364.394,100,200415-FTE / COVID-19,,,0,40,20,1181202-Y4-23,05_G,COC=1C=CC=CC1OC2CCN(C2)C(=O)C3=CC(=O)NC=4C=CC=CC34,"4-[3-(2-methoxyphenoxy)pyrrolidine-1-carbonyl]-1,2-dihydroquinolin-2-one"
ALP-POS-a3de0cb1-3,Z4656742096,C21H20ClN3O2S,Racemic or presumed racemic or meso,413.920,100,200415-FTE / COVID-19,hydrogen chloride,1,36.46094,40,20,1181202-Y4-23,05_H,Cl.COC=1C=CC(=CC1)C(CC=2C=CSC2)C(=O)NC3=NNC=4C=CC=CC34,N-(1H-indazol-3-yl)-2-(4-methoxyphenyl)-3-(thiophen-3-yl)propanamide hydrochloride
ALP-POS-a3de0cb1-10,Z4618924270,C21H21N5OS,Racemic or presumed racemic or meso,391.489,96.55,200415-FTE / COVID-19,,,0,40,20,1181202-Y4-23,05_I,CN(C)C=1C=CC(=CC1)C(CC=2C=CSC2)C(=O)NC3=NN=C4C=CC=CN34,"2-[4-(dimethylamino)phenyl]-3-(thiophen-3-yl)-N-{[1,2,4]triazolo[4,3-a]pyridin-3-yl}propanamide"
MAR-UCB-f313ec4d-3,Z1530720954,C19H18N2O3,Achiral,322.357,97.8,200415-FTE / COVID-19,,,0,40,20,1181202-Y4-23,05_J,COC=1C=CC=CC1OCCC(=O)NC=2C=NC=C3C=CC=CC23,N-(isoquinolin-4-yl)-3-(2-methoxyphenoxy)propanamide
MAT-POS-8e4737f4-2,Z4647468798,C19H15ClN2O2,Single known enantiomer,338.787,99,200415-FTE / COVID-19,,,0,40,20,1181202-Y4-23,05_K,"ClC=1C=CC=2OC[C@@H](CC2C1)C(=O)NC=3C=NC=C4C=CC=CC34 |o1:7,r|","rel-(3R)-6-chloro-N-(isoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-3-carboxamide"
EDJ-MED-e4b030d8-12,Z4647468795,C19H15ClN2O2,Single known enantiomer,338.787,100,200415-FTE / COVID-19,,,0,40,20,1181202-Y4-23,05_L,"ClC=1C=CC=2OC[C@H](CC2C1)C(=O)NC=3C=NC=C4C=CC=CC34 |o1:7,r|","rel-(3R)-6-chloro-N-(isoquinolin-4-yl)-3,4-dihydro-2H-1-benzopyran-3-carboxamide"
RAL-THA-6b94ceba-1,Z4609618475,C18H17ClN4O2,Achiral,356.806,91.38,200415-FTE / COVID-19,,,0,40,20,1181202-Y4-23,05_M,CC=1C=CN=CC1NC(=O)CC=2C=C(Cl)C=C(OCC3=NC=CN3)C2,2-{3-chloro-5-[(1H-imidazol-2-yl)methoxy]phenyl}-N-(4-methylpyridin-3-yl)acetamide
ERI-UCB-a0b0dbcb-9,Z4655756145,C20H18N2O4,Achiral,350.367,97.52,200415-FTE / COVID-19,,,0,40,20,1181202-Y4-23,05_N,COC=1C=CC=CC1OC2CN(C2)C(=O)C3=CC(=O)NC=4C=CC=CC34,"4-[3-(2-methoxyphenoxy)azetidine-1-carbonyl]-1,2-dihydroquinolin-2-one"
LOR-NOR-c954e7ad-3,Z330905748,C12H11NO4,Achiral,233.220,98.28,200415-FTE / COVID-19,,,0,40,20,1181202-Y4-23,05_O,CCC=1C=CC=2N(CC(=O)O)C(=O)C(=O)C2C1,"2-(5-ethyl-2,3-dioxo-2,3-dihydro-1H-indol-1-yl)acetic acid"
LOR-NOR-c954e7ad-4,Z111504232,C13H14BrNO2,Achiral,296.159,95,200415-FTE / COVID-19,,,0,40,20,1181202-Y4-23,05_P,CCCCN1C(=O)C(=O)C=2C=C(Br)C=C(C)C12,"5-bromo-1-butyl-7-methyl-2,3-dihydro-1H-indole-2,3-dione"
LOR-NOR-c954e7ad-5,Z324552784,C13H14BrNO2,Achiral,296.159,95,200415-FTE / COVID-19,,,0,40,20,1181202-Y4-23,05_Q,CC(C)CCN1C(=O)C(=O)C=2C=C(Br)C=CC12,"5-bromo-1-(3-methylbutyl)-2,3-dihydro-1H-indole-2,3-dione"
LOR-NOR-c954e7ad-6,Z352251436,C13H9BrN2O2S,Achiral,337.191,100,200415-FTE / COVID-19,,,0,40,20,1181202-Y4-23,05_R,CC1=NC(CN2C(=O)C(=O)C=3C=C(Br)C=CC23)=CS1,"5-bromo-1-[(2-methyl-1,3-thiazol-4-yl)methyl]-2,3-dihydro-1H-indole-2,3-dione"
LOR-NOR-c954e7ad-1,Z229837880,C15H10N2O4,Achiral,282.250,95,200415-FTE / COVID-19,,,0,40,20,1181202-Y4-23,05_S,[O-][N+](=O)C=1C=CC=2N(CC=3C=CC=CC3)C(=O)C(=O)C2C1,"1-benzyl-5-nitro-2,3-dihydro-1H-indole-2,3-dione"
LOR-NOR-c954e7ad-2,Z56793418,C10H6N2O6,Achiral,250.164,92,200415-FTE / COVID-19,,,0,40,20,1181202-Y4-23,05_T,OC(=O)CN1C(=O)C(=O)C=2C=C(C=CC12)[N+](=O)[O-],"2-(5-nitro-2,3-dioxo-2,3-dihydro-1H-indol-1-yl)acetic acid"
EDJ-MED-c8e7a002-15,Z4661830690,C14H10BrClN4O,Achiral,365.612,100,200415-FTE / COVID-19,,,0,40,20,1181202-Y4-23,05_U,ClC=1C=CC=C(CC(=O)NC2=NNC=3C=CN=C(Br)C23)C1,"N-{4-bromo-1H-pyrazolo[4,3-c]pyridin-3-yl}-2-(3-chlorophenyl)acetamide"
ALP-POS-477dc5b7-1,Z4655756136,C20H17ClN2O,Racemic or presumed racemic or meso,336.814,100,200415-FTE / COVID-19,,,0,40,20,1181202-Y4-23,05_V,ClC=1C=CC=2CCCC(C(=O)NC=3C=NC=C4C=CC=CC34)C2C1,"7-chloro-N-(isoquinolin-4-yl)-1,2,3,4-tetrahydronaphthalene-1-carboxamide"
MAT-POS-8a69d52e-5,Z4669835236,C20H17ClN2O2,Single known enantiomer,352.814,100,200415-FTE / COVID-19,,,0,40,20,1181202-Y4-23,05_W,"C[C@@H]1COC=2C=CC(Cl)=CC2[C@@H]1C(=O)NC=3C=NC=C4C=CC=CC34 |o1:1,11,r|","rel-(3R,4S)-6-chloro-N-(isoquinolin-4-yl)-3-methyl-3,4-dihydro-2H-1-benzopyran-4-carboxamide"
MAT-POS-8a69d52e-7,Z4669837363,C20H17ClN2O2,Single known enantiomer,352.814,100,200415-FTE / COVID-19,,,0,40,20,1181202-Y4-23,05_X,"C[C@H]1COC=2C=CC(Cl)=CC2[C@H]1C(=O)NC=3C=NC=C4C=CC=CC34 |o1:1,11,r|","rel-(3R,4S)-6-chloro-N-(isoquinolin-4-yl)-3-methyl-3,4-dihydro-2H-1-benzopyran-4-carboxamide"
EDJ-MED-e4b030d8-11,Z4669834442,C20H17ClN2O2,Single known enantiomer,352.814,100,200415-FTE / COVID-19,,,0,40,20,1181202-Y4-23,05_Y,"C[C@@H]1COC=2C=CC(Cl)=CC2[C@H]1C(=O)NC=3C=NC=C4C=CC=CC34 |o1:1,11,r|","rel-(3R,4R)-6-chloro-N-(isoquinolin-4-yl)-3-methyl-3,4-dihydro-2H-1-benzopyran-4-carboxamide"
MAT-POS-0c8fa4a7-2,Z4669992423,C16H14ClN3O2,Achiral,315.754,100,200415-FTE / COVID-19,,,0,40,20,1181202-Y4-23,05_Z,COC=1C=CC=2N(N=C(N)C2C1)C(=O)CC=3C=CC=C(Cl)C3,1-(3-amino-5-methoxy-1H-indazol-1-yl)-2-(3-chlorophenyl)ethan-1-one
EDJ-MED-c8e7a002-2,Z1550667938,C16H14ClN3O2,Achiral,315.754,100,200415-FTE / COVID-19,,,0,40,20,1181202-Y4-23,05_AA,COC=1C=CC=2NN=C(NC(=O)CC=3C=CC=C(Cl)C3)C2C1,2-(3-chlorophenyl)-N-(5-methoxy-1H-indazol-3-yl)acetamide
MAT-POS-8a69d52e-6,Z4669835830,C20H17ClN2O2,Single known enantiomer,352.814,100,200415-FTE / COVID-19,,,0,40,20,1181202-Y4-23,05_AB,"C[C@H]1COC=2C=CC(Cl)=CC2[C@@H]1C(=O)NC=3C=NC=C4C=CC=CC34 |o1:1,11,r|","rel-(3R,4R)-6-chloro-N-(isoquinolin-4-yl)-3-methyl-3,4-dihydro-2H-1-benzopyran-4-carboxamide"
ALP-POS-a3de0cb1-13,Z4618924281,C26H24ClN5O2,Racemic or presumed racemic or meso,473.954,98.31,200415-FTE / COVID-19,,,0,40,20,1181202-Y4-23,05_AC,ClC=1C=CC=C(CC(C(=O)NN2N=NC=3C=CC=CC23)C=4C=CC(=CC4)N5CCCCC5=O)C1,"N-(1H-1,2,3-benzotriazol-1-yl)-3-(3-chlorophenyl)-2-[4-(2-oxopiperidin-1-yl)phenyl]propanamide"